Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Lutetium Lu 177-Dotatate

Placeholder slot
 (loo-TEE-shee-um … DOH-tuh-tayt )

This page contains brief information about lutetium Lu 177-dotatate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Lutathera
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Lutetium Lu 177-dotatate is approved to treat:

Lutetium Lu 177-dotatate is also being studied in the treatment of other types of cancer.

More About Lutetium Lu 177-Dotatate

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Lutathera Shows Promise as Part of Initial Therapy for Some Neuroendocrine Tumors

Targeted Therapy to Treat Cancer

Radiopharmaceuticals: Radiation Therapy Enters the Molecular Age

Clinical Trials Accepting Patients

Find Clinical Trials for Lutetium Lu 177 Dotatate - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated:
Email